CYP21A2 and chronic primary adrenal insufficiency: In autoimmune AD (often termed autoimmune Addison disease, AAD), a consistent serological hallmark is the presence of 21-hydroxylase (CYP21A2) autoantibodies, detectable in ~85% of patients near diagnosis.